Addex Therapeutics (ADXN) Assets Average (2020 - 2026)

Addex Therapeutics has disclosed Assets Average across 7 years of filings, most recently posting $7.0 million for Q1 2026.

• In Q1 2026, Assets Average fell 38.25% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (down 38.25% YoY), while the FY2025 annual figure was $9.9 million, up 14.49% from the prior year.
• Assets Average came in at $7.0 million for Q1 2026 at Addex Therapeutics, down from $8.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $21.8 million in Q1 2022 to a low of $4.5 million in Q1 2024.
• Average Assets Average over 5 years is $10.6 million, with a median of $9.7 million recorded in 2025.
• Year-over-year, Assets Average plunged 62.19% in 2023 and surged 151.11% in 2025.
• Over 5 years, Assets Average stood at $10.6 million in 2022, then slumped by 42.73% to $6.1 million in 2023, then jumped by 115.35% to $13.1 million in 2024, then sank by 34.71% to $8.6 million in 2025, then declined by 18.02% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $7.0 million in Q1 2026, $8.6 million in Q4 2025, and $9.7 million in Q3 2025.